相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Cardiovascular Comorbidities and Pharmacological Treatments of COVID-19 Patients Not Requiring Hospitalization
Vincenzo Russo et al.
INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH (2021)
2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS)
Francois Mach et al.
EUROPEAN HEART JOURNAL (2020)
Clinical profile of direct oral anticoagulants versus vitamin K anticoagulants in octogenarians with atrial fibrillation: a multicentre propensity score matched real-world cohort study
Vincenzo Russo et al.
JOURNAL OF THROMBOSIS AND THROMBOLYSIS (2020)
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): The epidemic and the challenges
Chih-Cheng Lai et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2020)
The association between atrial fibrillation and Alzheimer's disease: fact or fallacy? A systematic review and meta-analysis
Riccardo Proietti et al.
JOURNAL OF CARDIOVASCULAR MEDICINE (2020)
Proportion of High-Risk/Very High-Risk Patients in Europe with Low-Density Lipoprotein Cholesterol at Target According to European Guidelines: A Systematic Review
Eric Bruckert et al.
ADVANCES IN THERAPY (2020)
Targeting LDL cholesterol: Early treatment is key to population health
Jane Stock
ATHEROSCLEROSIS (2020)
Clinical Outcome of Edoxaban vs. Vitamin K Antagonists in Patients with Atrial Fibrillation and Diabetes Mellitus: Results from a Multicenter, Propensity-Matched, Real-World Cohort Study
Vincenzo Russo et al.
JOURNAL OF CLINICAL MEDICINE (2020)
Non-vitamin K vs vitamin K oral anticoagulants in patients aged > 80 year with atrial fibrillation and low body weight
Vincenzo Russo et al.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2020)
COVID-19 and cardiac implantable electronic device remote monitoring:crocodile tears or new opportunity?
Vincenzo Russo et al.
EXPERT REVIEW OF MEDICAL DEVICES (2020)
The role of telehealth during COVID-19 outbreak: a systematic review based on current evidence
Elham Monaghesh et al.
BMC PUBLIC HEALTH (2020)
COVID-19 and Heart: From Clinical Features to Pharmacological Implications
Vincenzo Russo et al.
JOURNAL OF CLINICAL MEDICINE (2020)
Telemedicine consultation for the clinical cardiologists in the era of COVID-19: present and future. Consensus document of the Spanish Society of Cardiology
Vivencio Barrios et al.
REVISTA ESPANOLA DE CARDIOLOGIA (2020)
Arrhythmogenic syncope leading to cardiac rhythm management procedures during COVID-19 lockdown
Vincenzo Russo et al.
EXPERT REVIEW OF MEDICAL DEVICES (2020)
Short-term outcome associated with remote evaluation (telecardiology) of patients with cardiovascular diseases during the COVID-19 pandemic
Massimiliano Maines et al.
IJC HEART & VASCULATURE (2020)
Reduction of hospitalizations for myocardial infarction in Italy in the COVID-19 era
Salvatore De Rosa et al.
EUROPEAN HEART JOURNAL (2020)
Reduction of hospitalizations for myocardial infarction in Italy in the COVID-19 era
Salvatore De Rosa et al.
EUROPEAN HEART JOURNAL (2020)
Global Telemedicine Implementation and Integration Within Health Systems to Fight the COVID-19 Pandemic: A Call to Action
Robin Ohannessian et al.
JMIR PUBLIC HEALTH AND SURVEILLANCE (2020)
Atrial Fibrillation and Malignancy: The Clinical Performance of Non-Vitamin K Oral AnticoagulantsA Systematic Review
Vincenzo Russo et al.
SEMINARS IN THROMBOSIS AND HEMOSTASIS (2019)
Lifestyle and impact on cardiovascular risk factor control in coronary patients across 27 countries: Results from the European Society of Cardiology ESC-EORP EUROASPIRE V registry
Kornelia Kotseva et al.
EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY (2019)
Real-life Performance of Edoxaban in Elderly Patients With Atrial Fibrillation: a Multicenter Propensity Score-Matched Cohort Study
Vincenzo Russo et al.
CLINICAL THERAPEUTICS (2019)
The Role of Cardiovascular and Metabolic Comorbidities in the Link between Atrial Fibrillation and Cognitive Impairment: An Appraisal of Current Scientific Evidence
Ahmed AlTurki et al.
MEDICINA-LITHUANIA (2019)
Clinical Benefit of Direct Oral Anticoagulants Versus Vitamin K Antagonists in Patients with Atrial Fibrillation and Bioprosthetic Heart Valves
Vincenzo Russo et al.
CLINICAL THERAPEUTICS (2019)
Dosing issues with non-vitamin K antagonist oral anticoagulants for the treatment of non-valvular atrial fibrillation: Why we should not underdose our patients
Jean-Guillaume Dillinger et al.
ARCHIVES OF CARDIOVASCULAR DISEASES (2018)
The 2018 European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation
Jan Steffel et al.
EUROPEAN HEART JOURNAL (2018)
Nonvitamin K Antagonist Oral Anticoagulants Use in Patients with Atrial Fibrillation and Bioprosthetic Heart Valves/Prior Surgical Valve Repair: A Multicenter Clinical Practice Experience
Vincenzo Russo et al.
SEMINARS IN THROMBOSIS AND HEMOSTASIS (2018)
Influence of Renal Function on the Pharmacokinetics, Pharmacodynamics, Efficacy, and Safety of Non-Vitamin K Antagonist Oral Anticoagulants
Matthew R. Weir et al.
MAYO CLINIC PROCEEDINGS (2018)
Efficacy and safety of the target-specific oral anticoagulants for stroke prevention in atrial fibrillation: the real-life evidence
Vincenzo Russo et al.
THERAPEUTIC ADVANCES IN DRUG SAFETY (2017)
The epidemiological concept of residual risk
Diego Vanuzzo
INTERNAL AND EMERGENCY MEDICINE (2011)
分享论文
